In light of the reduced success of previous attempts to correct genetic alterations in pancreatic cancer through gene therapy, these considerations also highlight the possibility that early intervention against stress-induced proteins may be more beneficial for the management of this cancer and likely other malignancies, which are known to associate with Kras mutations. Here, KRAS is linked to cancer.